Latest news articles

Added 3 days ago Drug news

CE Mark for Myval transcatheter aortic heart valve.-Meril Life Sciences.

Meril Life Sciences, a company based in India, has obtained the European CE mark of approval for its Myval transcatheter...

Added 1 month ago Drug news

The COMMENCE study shows that bioprosthetic surgical aortic valves with RESILIA tissue platform continue to demonstrate favorable safety and hemodynamic performance through four years follow-up. Edwards Lifesciences.

Edwards Lifesciences Corporation announced results from the COMMENCE clinical study. The data show that Edwards' bioprosthetic surgical aortic valves featuring...

Added 1 month ago Drug news

FDA approves LOTUS Edge Aortic Valve System to treat severe aortic stenosis

Boston Scientific Corporation announced it has received FDA approval for the LOTUS Edge Aortic Valve System. Delivered via a minimally-invasive...

Search all news articles for Heart valve disorders

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Oral Anticoagulation Reversal

Oral Anticoagulation Reversal

Experts discuss the use of non-vitamin K oral anticoagulants in the treatment and prevention of stroke, deep vein thrombosis and pulmonary embolism in atrial fibrillation patients.

Acute and Advanced Heart Failure

Acute and Advanced Heart Failure

What are the most effective treatments for acute heart failure? Can you define advanced heart failure? Discover here...

+ 3 more

Load more


2017 ESC/EACTS Guidelines for the management of valvular heart disease

These guidelines focus on acquired VHD, are oriented towards management and do not deal with endocarditis or congenital valve disease, including pulmonary valve disease, as separate guidelines have been published by the ESC on these topics.

Added 6 years ago

Search all guidelines for Heart valve disorders

Journal articles

Safety and Feasibility of Treatment with Rivaroxaban for Non-Canonical Indications: A Case Series Analysis.

The new oral anticoagulants (NOACs) are used for the prevention of thromboembolic complications in patients with non-valvular atrial fibrillation (AF) and those at risk of deep venous thrombosis.

Added 2 years ago

Predictors of reversible severe functional tricuspid regurgitation in patients with atrial fibrillation.

Background: Atrial remodeling associated with atrial fibrillation (AF) is known to be a risk factor for significant tricuspid regurgitation (TR),...

Added 3 years ago

Search all journal articles for Heart valve disorders


Innocent cardiac murmurs in children

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
Registration required
Subscription fee
Search all CME for Heart valve disorders